Surgical removal of the thymus of newborn mice is usually associated with "wasting," with a marked deficiency in the lymphocyte population of the blood, spleen and other lymphoid tissues, and with immunologic deficits, particularly of cell-mediated responses such as the immune reactions of homograft rejection and delayed hypersensitivity reactions. ' The results of thymectomy performed at three to seven days, however, are modified to the extent that "wasting" does not occur and there is a minimal lymphocyte depletion, but the animal is still deficient in its ability to reject allogeneic grafts of normal or neoplastic tissues especially when antigenic differences are slight, for example, if donor and recipient differ in their makeup of weak histocompatibility genes. '-' Thymectomy in the neonatal period also results in an increased suceptibility to the oncogenic effects of polyoma virus. Such observations have been recorded for the mouse,2 4' 5 rat,6' 7 and the Syrian hamster.8
In this study we have taken advantage of the animal with a deficient immune mechanism in order to identify the factors of host resistance to polyoma virusinduced neoplasms. C57BL/Ka strain mice remain free of polyoma-type neoplasms, even if virus is given in high concentration at birth.3' I This resistance, which is genetically determined,3 is broken by neonatal thymectomy. Seventy to 90 per cent of C57BL mice thymectomized at 3 days of age develop neoplasms, principally of the salivary glands, if polyoma virus is given up to 10 days of age and some sensitivity to respond is retained up to at least 30 days.2 This striking increase in susceptibility to the oncogenic effects of polyoma virus is known not to be due to differences in virus growth patterns or differences in antibody formation or concentration.2 That the insensitivity to oncogenesis is related to defense mechanisms operating at the level of the organism is shown by the ability of polyoma virus to transform cells of organ explants to neoplastic growths. 10 It is quite clear that polyoma-induced tumor cells, free of intact virus, are antigenic.'1' 12 They contain a virus-specific "new" cellular antigen, the transplantation-resistance antigen, TR, which is found to be effective in "sensitizing" immunologically competent mice to reject transplants of polyoma tumors and, more significantly, to prevent the induction of neoplasms by polyoma virus in the autochthonous host.2' 9 Immune mechanisms in both situations apparently are of the cellular, homograft-rejection type."3-5 It has been shown recently that the excess frequency of primary neoplasms may be prevented in immunologically deficient thymectomized mice by the following restorative procedures:2 (1) injection of syngeneic spleen or lymph node cells from intact but not from thymectomized donors, (2) grafting of syngeneic thymic tissue, or (3) syngeneic thymic tissue in Millipore diffusion chambers. Each of these procedures is known to restore immunologic competence.
An attempt was made in the present study to utilize the antigenic difference, TR antigen, between tumor and host to control the induction of neoplasms in the autochthonous host not by restoration of the host's immune competence but through adoptively acquired immunity, that is, through the transfer from a syngeneic donor of lymphoid cells sensitized by TR antigen. Sensitized lymphoid cells were transferred at various times up to 60 days after polyoma virus infection of the test animals.
Materials and Methods.-Mice: Inbred C57BL/KaLw of our colony were used for thymectomies and as donors of syngeneic lymphoid cells and serum. C3Hf/HeN subline mice were used as allogeneic donors of spleen cells.
Virus: The LID-1 standardized large-plaque polyoma virus stock has been used throughout. This virus has been cloned by plaqueing and maintained on mouse embryo cells. All of the mice reported here were injected subcutaneously when 7 to 9 days of age with a 0.1-ml volume representing 2 X 106 plaque-forming units (PFU). Concentrations of virus were determined by the method of Dulbecco and Freeman. 16 Transplantable polyoma tumors: The fibrosarcoma designated 4198 originated in vitro in tissues derived from a C3Hf/HeN strain mouse and infected with polyoma virus.'5 Polyoma tumor 89 originated in the tissues of the parotid gland of a C57BL/KaLw thymectomized mouse.'2 In the early transplant generations this neoplasm was pleomorphic but later became fibrosarcomatous. Both neoplasms grow progressively in and kill their syngeneic hosts. These tumors are free of demonstrable virus as determined by the hemagglutination-inhibition test and by plaque formation, and both are known to contain polyoma virus-specific transplantation antigens and have maintained this character through many in vivo and in vitro transfers.
Immunization procedures: Adult C57BL mice, 1-2 months old, were inoculated subcutaneously with 2 X 106 trypsinized allogeneic tumor cells in tris buffer; the tumor was 4198 of C3H origin as described above. Second and third inoculations were made at 2 and 3 weeks after the first. Three weeks after the last immunizing dose of tumor cells, the mice were challenged with the virus free syngeneic polyoma-induced tumor, 89. Those animals which completely resisted challenge with 2 X 105 tumor cells were considered immune and used as donors of lymphoid cells and serum.
Mice prepared as donors of sensitized allogeneic cells were of the C3Hf/HeN strain, received similar inoculations of the C57BL allogeneic tumor cells (tumor 89), and were challenged 3 weeks after the last immunization by syngeneic C3H, 4198, cells. Tumor cells were always from in vitro passages. C57BL adults were also immunized by an alternate procedure: subcutaneous injection of LID-1 virus was given at a concentration of 2 X 106 PFU in a 0.2-ml volume. These were challenged 3 weeks later with 2 X 105 syngeneic, tumor 89, cells. All of these mice rejected these syngeneic tumor cells.
Preparation of normal and immune lymphoid cells and serum: Dissociated lymphoid cells were obtained from the spleen or from the combined cervical, axillary, brachial, and inguinal lymph nodes and prepared by the method described by Billingham.17 These cells were obtained either from the hyperimmunized mice described above or from control, nonimmune (polyoma HInegative) littermates. Cells were inoculated intravenously, except where otherwise noted, at the ages indicated in the tables. The weight-adjusted concentration was 2 X 106 cells per gram of body weight. In younger mice the anterior facial vein was used and the volume injected was 0.1 ml, whereas in older mice the lateral tail vein was used and the volume injected was 0.2 ml.
Serum was obtained by cardiac puncture from the same hyperimmunized mice which yielded syngeneic lymphoid cells. This was given to only one age group in 3 injections, 2 days apart. The first injection of 0.2 ml per mouse was fresh serum and subsequent injections were of serum stored at -20'C. Thymectomies: Mice were thymectomized when 3 days of age; ether anesthesia was used. In each individual experiment intact or sham-operated controls were included as well as thymectomized controls. Thus, experimental mice were caged with both types of controls. Those mice observed at necropsy to have thymic tissue remnants in the anterior mediastinum were excluded from the experiment; these constituted less than 5% of the total necropsies. Results.-The high frequency of neoplasms observed previously in thymectomized C57BL mice,2' 9 following polyoma virus infection, was observed in this study, although virus infection was accomplished here at a later time, that is, at 7 to 9 days of age. These were the typical pleomorphic neoplasms of salivary glands, principally of the parotid gland, described previously. 18 An occasional hair follicle tumor or neoplasm of the subcutaneous connective tissues was seen. No neoplasms were observed, however, over a 14-month observation period in the intact control littermates (group VI, Table 1 ).
Syngeneic lymphoid cells obtained from the spleens of nonimmunized mice were indeed relatively effective in preventing neoplasms in virus-infected mice, particularly when given as late as 8-12 days after virus infection (Table 1) .
There was obtained a lesser effect and in some experiments no effect in preventing the induction of primary neoplasms if nonsensitized lymphoid cells were inoculated during the period from 14 to 30 days after virus infection (groups III and IV).
In contrast to the groups receiving nonsensitized lymphoid cells, no neoplasms were observed in 67 thymectomized, virus-infected mice given 2 X 106 cells/gm body weight of syngeneic spleen cells from hyperimmunized donors at the various times following virus infection up to and including the period of 30-35 days. Twenty-five of 30 of these mice (group IV, Table 1 ) received sensitized cells from donors hyperimmunized through the use of virus-free allogeneic tumor cells, so that prevention is not attributable to transfer of intact virus which could actively immunize the host. This transfer of immunity by sensitized cells is apparently long-lasting and is effective within a short period of time after transfer.
A likely explanation for the observed differences between the efficacy of the transferred sensitized versus nonsensitized lymphoid cells in preventing tumor induction in a syngeneic system is as follows: lymphoid cells, as well as other hematopoietic cells, would be expected to seed out, become established in lymphoid organs, continue to divide and recirculate, and in time re-establish immunologic competence particularly in the thymectomized host. Nonsensitized lymphoid cells in order to become effective must in addition come in contact with antigen (either virus or newly arisen tumor cells containing TR antigen); that is, they must have time to acquire an active immunity. If these cells are transferred early after virus infection, there is ample time to mount an effective immune response against neoplastic target cells. After a period of 14-25 days there is not apparently an adequate period of time to do this. Sensitized cells, on the other hand, have the capacity to evoke a cellular immune reaction immediately upon seeding out and becoming established. This represents a true adoptively acquired immune response; these cells then apparently have a long tenure of effect.
We have observed clones of presumably neoplastic cells in 60 per cent of mice (6 out of 10) through a study of serial sections of parotid glands taken from C75BL mice at 30 days after virus infection; yet sensitized lymphoid cells given at this time completely prevent the induction of frank neoplasms.
There appears also to be a significant effect in preventing the induction of neoplasms in thymectomized mice by sensitized lymphoid cells injected in the period 45-60 days after polyoma virus infection. Seventy-five per cent of thymectomized controls (60/80) but only 54.6 per cent (18/38) of treated mice developed polyomatype neoplasms (see Tables 1 and 2 ). The difference in percentages is 20 .4 i 9.5 per cent (P = 0.032).
In a sample of six C57BL mice treated at 30 days with sensitized lymphoid cells and sacrificed 14 months later for sectioning of all salivary glands submaxillary and sublingual as well as parotid, no nests of neoplastic cells could be found. These findings suggest the likelihood that sensitized lymphoid cells are capable of eliminating neoplastic cells by an immune reaction.
The results recorded in Table 2 are in accord with expectations if the thesis is accepted that immunity is of the homograft rejection type and is transferred by sensitized lymphoid cells which function in the recipient. That cells of the lymphoid series were the effective cells is shown in experiment 6. Cells obtained from lymph nodes of hyperimmune syngeneic mice were as effective as cells obtained from the spleen, at the one level tested (2 X 106 cells/gm body weight). Recently, Agnew7 has shown that lymphocytes obtained from thoracic duct drainage of inbred Lewis strain rats are most effective in restoring resistance to polyoma tumor induction.
Sensitized cells from allogeneic (C3H) donors were ineffective; this would be expected if these cells are rejected by a homograft reaction.
Serum from those hyperimmunized C57BL donors which provided effective lymphoid cells gave negative results. Attempts to transfer a state of heightened resistance with serum against skin grafts and tumors have indeed been uniformly unsuccessful'9 20 except in special cases of dissociated leukemic cells.2' Irreversible cell damage resulting from freezing, irradiation, and other agents is known to prevent the transfer of immunity by lymphoid cells.22 In the present work 5000 r X irradiation just prior to the intravenous inoculation of sensitized splenic cells prevented the inhibitory effect of these cells.
There appears to be a quantitative relationship between the number of sensitized cells transferred and the ability to confer immunity; 2 X 103 cells per gram of recipient were less effective in preventing polyoma virus-induced neoplasms, when administered at 30 days, than higher levels of cells. It is of interest to note that sensitized cells inoculated by the intraperitotneal route were also effective at certain dosage levels. In the majority of individual experiments listed in Table 2 , sensitized cells were obtained from syngeneic donors that had been hyperimmunized with a virus-free allogeneic tumor. These cells were as effective in preventing tumor induction as those obtained from polyoma virus-immunized donors.
Discussion.-There is no reason to doubt the existence of polyoma virus-specific cellular transplantation antigens, TR, unrelated to viral antigens. These have been detected through the use of transplantable tumors and in studies employing primary hosts made immunologically deficient through neonatal thymectomy. The resistance of C57BL mice to polyoma virus oncogenesis is related directly to im-munologic capacity; cellular immunity of the homograft type invoked against "tumor" antigen TR contained in neoplastic cells is involved. In the immunologically deficient animal, the "tumor" antigens are not capable of evoking an effective immunological attack on clones of cells transformed to neoplasia by virus. Neoplastic clones, therefore, grow progressively into frank neoplasms. In the immunological competent animal, either intact or restored by several methods, neoplastic conversion does occur but the transformed cells are aborted by a successful homograft reaction.
In the present study passive transfer of transplantation immunity was achieved and is shown to be effective in preventing the induction of progressively growing polyoma-type neoplasms, even when transfer was achieved as late as 30 days after virus infection.
As pointed out in the early classic studies of adoptively acquired immunity,22 an obligatory design of experiments to demonstrate passive transfer of immunity is that primary and secondary hosts be members of the same highly inbred strain.
We have used throughout this study the syngeneic C57BL/KaLw strain as donors and recipients.
The simplest interpretation of the findings reported here is that the inoculation of the immunologically deficient, polyoma virus-infected mice with immunologically active (sensitized) lymphoid tissues converted them to actively immunized animals following seeding out and establishment of the cells, which then resisted polyoma virus oncogenesis. This interpretation is strengthened by the findings that nonsensitized lymphoid cells were relatively ineffective when administered after approximately two weeks following virus infection. Apparently these cells require time after becoming established to become sensitized within the environment of the recipient animal by a process of active sensitization.
The other findings reported here, the inefficacy of X-irradiated cells, of sensitized allogeneic lymphoid cells, and of serum from hyperimmunized syngeneic mice are analogous to observations, already made, in other systems of the transfer of immunity by cells.
The exact mechanism of suppression of polyoma virus-induced neoplasms by adoptively acquired immunity is not known; presumably, the neoplastic cells containing TR antigen are effectively eliminated rather than held in check since neoplastic cells were not found in serial sections of salivary glands of those mice examined 14 months after virus infection. It does appear that there is a critical size limit of the tumor cell mass in order to achieve progressive growth of the neoplasm, which, if attained, is not influenced by passively transferred, sensitized lymphoid cells. Minimal inhibitory effects were observed when cells were administered in the period 45-60 days after virus infection.
The results of previous studies of the efficacy of lymphoid cells in inhibiting tumor growth have been equivocal." Only a single instance has been recorded of a specific adoptive immunity observed in a syngeneic system; this study was concerned with the effects of transferred, sensitized spleen and lymph node cells on the growth rates of a transplantable carcinogen-induced neoplasm in mice."2 An inhibitory effect was obtained only if lymphoid cells were inoculated prior to tumor challenge. In several instances inhibition of growth of transplantable neoplasms has been recorded when tumor cells are mixed with lymph node or spleen cells prior to inoculation into syngeneic hosts.23-26 The mechanism of inhibition in the in vitro mixing experiments is not clear since lymph nodes cells from nonsensitized donors were also inhibitory. Furthermore, lymphoid cells known to be effective inhibitors of the growth of transplantable tumors following in vitro mixing were found to be noninhibitory if transferred instead to the syngeneic host. The recent reports of Alexander and co-workers,27' describing an inhibition of growth of primary, chemically induced fibrosarcomas in the rat by passively transferred sensitized thoracic-duct lymphocytes, suggest the operation of a cellular immune response. Unfortunately, these studies were carried out principally in a nonsyngeneic system.
Sumnmary.-Polyoma virus-induced neoplasms in C57BL strain mice were totally prevented through adoptively acquired immunity. Sensitized lymphoid cells inoculated intravenously were effective if administered as late as 30 days after virus infection.
Sensitized allogeineic lymphoid cells, killed syngeneic cells, and serum from hyperimmunized donors were ineffective.
The results show that the antigenic difference between tumor and host can be used to control primary tumors. The evidence suggests that clones of neoplastic cells induced by virus and containing TR antigen are eliminated by an immune reaction of the homograft type. 
